European Pharma Outsourcing Summit
Lunch & Learn
Roundtables
Day 1
12.40 – 13.40 CET
12.40 – 13.40 CET
TABLE 1
Saloni Wagh
Managing Director
Supriya Lifescience Ltd.
Shireesh Ambhaikar
Technical Lead
Supriya Lifescience Ltd.
Building Resilient API Supply Networks Through Strategic Manufacturing Partnerships
Spots Remaining: 0
Brandon Geissler
ExM
Jacqueline Gijsberts
Orifarm
Justine Witosch
Boehringer Ingelheim Pharma GmbH & Co.KG
Maria Rosa Todeschi
PIAM Farmaceutici
Tammo Sassen
Grünenthal GmbH
Thibaut Chappelat
Alfred E. Tiefenbacher
Yasmine Zaraidi
Ipsen Pharma
Yassin Farag
Bayer AG
TABLE 2
Siyu Sheng
Associate Director, Business Development
Novartis Contract Manufacturing
Building Resilient Supply Chains: Regional Capacity Strategies for an Uncertain World
Spots Remaining: 0
Carles Olasolo
Neuraxpharm Pharmaceuticals S.L.
David Giera
Biofrontera Pharma GmbH
Elizabeth Leitning
Compass Pathways
Gijs Vissers
Nordic Pharma
Lars Broseit
Boehringer Ingelheim Animal Health
Laura Tenorio
Sanofi
Manuel Roig
Neuraxpharm
Ouelid Ouyeder
Bayer AG
Tomi Yoshida
Orion
TABLE 3
Amit Shrivastava
Chief Marketing Officer
R L Fine Chem
Rajesh Naik
Executive Director
R L Fine Chem
Leveraging CDMO Capabilities to Accelerate Scale-Up, Technology Transfer, and Commercial Readiness
Spots Remaining: 1
Anda Andreianu
Britannia Pharmaceuticals Ltd
Aurelie Wingert
Pierre Fabre
Gary Metcalfe
CNX-Therapeutics
Jennie Deutgen
Pfizer Health AB
José Correia
Pierre Fabre
Katarzyna Lew-kiedrowska
LEO Pharma
Matt Collins
CNX Therapeutics
Xavier Drozak
UCB
TABLE 4
Radek Fialka
VP, CDMO
medac
Handling Complexity: Aseptic Fill & Finish for High-Potency & ADC Products
Spots Remaining: 0
David Letipichia
Norgine
Ivan Franco
Boehringer Ingelheim
Jacqueline Mccarthy
STADA ARZNEIMITTEL AG
Marina Palumbo
Pfizer
Mark Djeneralovic
Astellas Pharma Europe Ltd
Mary Kyne
Astellas Ireland Co. Ltd
Sakhana Uthayakumar
Britannia Pharmaceuticals; STADA Group
Sebastiano Mozzo
Formycon
Stefano Talami
Piam Farmaceutici
Day 2
12.25 – 13.25 CET
12.25 – 13.25 CET
TABLE 1
Golo Heckmann
Head, API and Chemical Process Development, Animal Health
Boehringer Ingelheim
From External Development to Commercial Supply – Building Resilient GMP‑Compliant API Networks
Spots Remaining: 0
Carina Syring
Bristol Myers Squibb
Caroline Chardonnet
UCB
Dr Saloni Wagh
Supriya Lifescience
Isabell Weber-ziemann
OPELLA
Kushal Suri
Morepen
Olha Zasyadivko
Octapharma
Raj Sharma
Aurigene Pharmaceutical Services
Stefan Van Thiel
Fareva
Yassin Farag
Bayer AG
TABLE 2
Joana Gaspar
Associate Director, CMC Compliance Strategy, Integrations
Grünenthal
From Compliance to Product Excellence: Strategic Evolution of CMC
Spots Remaining: 1
Biermann Thorsten
Tianyu Pharma
Francesca Capelli
Gilead
Ginesh Raj R
Aurigene Pharmaceutical Services
Liesbeth Foesters
UCB Pharma
Matthias Beck
medac CDMO
Shireesh Ambhaikar
Supriya Lifescience
Stefano Talami
Piam Farmaceutici
Uwe Kraeker
Arxada
TABLE 3
Marty Hughes
Executive Director, CMC
Immuneering
Building Adaptive Operations to Withstand Geopolitical Shifts and Regulatory Disruptions
Spots Remaining: 0
Filipe Pires
IPSEN Pharma
Gary Metcalfe
CNX-Therapeutics
Ivan Franco
Boehringer Ingelheim
Jennie Deutgen
Pfizer Health AB
Jieeun Lee
Bristol Myers Squibb
Lars Broseit
Boehringer Ingelheim Animal Health
Nilesh Shah
Arxada
Rosalinda Pennella
Octapharma
Sebastiano Mozzo
Formycon
TABLE 4
Katherine Barton
Senior Director, CMC Global Regulatory Affairs
Fulcrum Therapeutics
Bridging CMC Innovation and Regulatory Compliance for Global Manufacturing Agility
Spots Remaining: 5
Andrea Hering
Medac GmbH
Diane Aguirre
Gilead Sciences
Girish Chandrashekhar
Cadila Pharmaceuticals Limited
Matt Collins
CNX Therapeutics
TABLE 5
Joseph Vu
Executive Director, Regulatory Affairs, Strategy and CMC
Taiho Oncology
Enhancing CMC Quality Assurance to Strengthen Global External Manufacturing Networks
Spots Remaining: 6
Anna Löfgren
Hansa Biopharma AB
Aurelie Wingert
Pierre Fabre
José Correia
Pierre Fabre
TABLE 6
Marina Palumbo
Senior Director, Cluster Head, External Supply Operations, Quality
Pfizer
Strengthening External Supply Quality Operations to Protect Supply and Compliance Globally
Spots Remaining: 0
David Giera
Biofrontera Pharma GmbH
Gessica Truglio
UCB
Jacqueline Mccarthy
STADA ARZNEIMITTEL AG
Mark Djeneralovic
Astellas Pharma Europe Ltd
Mary Kyne
Astellas Ireland Co. Ltd
Ouelid Ouyeder
Bayer AG
Thibaut Chappelat
Alfred E. Tiefenbacher
Tomi Yoshida
Orion
Yasmine Zaraidi
Ipsen Pharma
TABLE 7
Emma Newton
Head, Product Quality Assurance
Astellas Pharma Europe
Partnering for Quality: Aligning CMO Excellence with Pharma QA Expectations
Spots Remaining: 0
Albert Shi
Tianyu Pharmaceticals
Elisa Monari
chiesi farmaceutici
Elizabeth Leitning
Compass Pathways
Henk Mollee
Astellas
Laura Cappuccio
Gilead
Malene Anker Hansen
Orifarm
Mr Srinivas Muta
Morepen Laboratories Ltd
Nenad Ruzic
STADA AG
Piero Durso
chiesi
Sakhana Uthayakumar
Britannia Pharmaceuticals; STADA Group
TABLE 8
Salomon Engels
Head, External Manufacturing
Par Health (formerly Mallinckrodt-Endo)
Defining the KPIs That Improve Vendor Performance and Operational Reliability
Spots Remaining: 1
Anda Andreianu
Britannia Pharmaceuticals Ltd
Gijs Vissers
Nordic Pharma
Julia Pelatan
UCB Pharma
Justine Witosch
Boehringer Ingelheim Pharma GmbH & Co.KG
Maria Rosa Todeschi
PIAM Farmaceutici
Tammo Sassen
Grünenthal GmbH
Vaibhavi Modi
Grünenthal GmbH
Xavier Drozak
UCB